Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Slides:

Advertisements

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Advertisements

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Is long vein bypass from groin to ankle a durable procedure

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

Richard M. Green, MD, William M

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Venous claudication successfully treated by distal superficial femoral—to—greater saphenous venous bypass Mouhamad O. Annous, M.D., Luis A. Queral, M.D.

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Creation and closure of temporary arteriovenous fistulas for venous reconstruction or thrombectomy: Description of technique Richard J. Sanders, M.D.,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease? Marc A. Passman,

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

A new valvulotome for in situ bypass grafts

Axillofemoral bypass: A tool with a limited role

Malcolm O. Perry, MD, Richard Kempczinski, MD

Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Peripheral atherectomy with the rotablator: A multicenter report

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Objective tinnitus resulting from internal carotid artery stenosis

Factors affecting the patency of infrainguinal bypass

Long-term outcome after early infrainguinal graft failure

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Antonio V. Sterpetti, M. D. , Richard D. Schultz, M. D. , Richard J

Recreational weight lifting and aortic dissection: Case report

Calvin B. Ernst, MD Journal of Vascular Surgery

The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE grafts Mark R. Jackson, MDa, Todd P. Belott, MDa,

Long-term assessment of cryopreserved vein bypass grafting success

Flow waveform assessment of polytetrafluoroethylene grafts for reconstruction of lower extremity arteries Kenichiro Okadome, M.D., Taizo Miyazaki, M.D.,

Cardiovascular surgery—The rocket and its stars: Presidential address

Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts C.J. Buckley, MD, S. Abernathy,

The fate of the donor artery in extraanatomic revascularization

Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: The failure of low-density seeding to improve patency Malcolm Herring, MD,

Composite sequential bypasses to the ankle and beyond for limb salvage

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Research and research funding in vascular surgery

Regarding “Venous ulcers and the superficial venous system”

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

A simple technique to protect subcutaneous vein grafts

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Angioscopy-guided semiclosed technique for in situ bypass with a novel flushing valvulotome: Early results Peter Stierli, MD, Peter Aeberhard, MD Journal.

Isolated profundaplasty for limb salvage

A metropolitan experience with infrainguinal revascularization

Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein

Peter G. Kalman, M. D. , Marilyn Hosang, R. N. , Claudio Cina, M. D

Monitoring vascular surgical performance

Glenn C. Hunter, M.D., Stan N. Carson, M.D.

Homologous veins as an arterial substitute: Long-term results

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

D. Emerick Szilagyi, MD—An appreciation

Presidential address: The second-generation vascular surgeon

George D. Lilly 1906–1988 Journal of Vascular Surgery

Determinants of successful peroneal artery bypass

James A. DeWeese, MD Journal of Vascular Surgery

Femur fracture with limb shortening causing occlusion of a polytetrafluoroethylene femoral popliteal graft Joshua I. Ellenhorn, MD, Richard J. Fowl,

Jerry Goldstone, MD Journal of Vascular Surgery

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Robert R.M. Gifford, M.D. Journal of Vascular Surgery

Thigh claudication due to profunda femoris artery occlusion

Lessons learned in adopting the in situ saphenous vein bypass

Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein Spence M. Taylor,

Presentation transcript:

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass Jens H. Eickhoff, M.D., Albert Broomé, M.D., Björn F. Ericsson, M.D., Hans Jørgen Buchardt Hansen, M.D., Karl Frederik Kordt, M.D., Christian Mouritzen, M.D., Knut Kvernebo, M.D., Lars Norgren, M.D., Hans Rostad, M.D., Arne Trippestad, M.D. Journal of Vascular Surgery Volume 6, Issue 5, Pages 506-511 (November 1987) DOI: 10.1016/0741-5214(87)90311-9 Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 1 Accumulated graft patency rates [S(t)] for all grafts (PTFE, n = 55; HUV, n = 50). At 1 year 27 PTFE grafts were at risk, at 2 years 14 grafts, at 3 years 11 grafts, and at 4 years three grafts. The corresponding figures for HUV grafts were 37, 22, 19, and 8. Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 2 Accumulated graft failure intensity rates [β(t)] for all grafts (PTFE, n = 55; HUV, n = 50). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 3 Accumulated graft patency rates [S(t)] in limbs affected with intermittent claudication (PTFE, n = 12; HUV, n = 13). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 4 Accumulated graft patency rates [S(t)] in limbs affected with rest pain, ulceration, or gangrene (PTFE, n = 43; HUV, n = 37). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 5 Accumulated graft patency rates [S(t)] in limbs with good distal runoff (PTFE, n = 37; HUV, n = 32). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 6 Accumulated graft patency rates [S(t)] in limbs with poor runoff (PTFE, n = 18; HUV, n = 18). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 7 Accumulated graft patency rates [S(t)] in 55 limbs allocated to PTFE (5 mm, n = 34; 6 mm, n = 21). Journal of Vascular Surgery 1987 6, 506-511DOI: (10.1016/0741-5214(87)90311-9) Copyright © 1987 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions